You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TG-1101

Showing 26 - 50 of 473
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))

Completed
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Taichung City, Taiwan
  • +3 more
Nov 17, 2022

Granuloma Annulare Trial in New Haven (AC-1101)

Recruiting
  • Granuloma Annulare
  • New Haven, Connecticut
    Yale Center for Clinical Investigation
Nov 2, 2022

High Triglycerides Trial (NST-1024, Placebo)

Not yet recruiting
  • High Triglycerides
  • (no location specified)
May 25, 2023

Thyroglobulin Point of Care Assay for Rapid Detection of

Recruiting
  • Differentiated Thyroid Cancer
  • Lymph Node Metastases
  • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
  • Ashkelon, Israel
  • +2 more
Oct 25, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

Withdrawn
  • Myelodysplastic Syndrome
  • SyB C-1101 and Azacytidine
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

HPV Infection, Sexually Transmitted Infections and Anal

Not yet recruiting
  • Human Papillomavirus Infection
  • +2 more
    • (no location specified)
    Aug 1, 2023

    Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

    Completed
    • Myelodysplastic Syndrome
    • SyB C-1101
    • Nagoya, Aichi, Japan
    • +8 more
    Nov 14, 2022

    Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

    Not yet recruiting
    • Insulin Resistance
    • +3 more
    • Insulin human
    • +11 more
    • New York, New York
      Columbia University Irving Medical Center
    Nov 6, 2023

    Advanced Refractory Solid Tumors Trial in Kaohsiung, Tainan (T-1101 (Tosylate))

    Recruiting
    • Advanced Refractory Solid Tumors
    • T-1101 (Tosylate)
    • Kaohsiung, Taiwan
    • +1 more
    Oct 31, 2021

    Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • SyB L-1101
    • Nagoya, Aichi, Japan
    • +2 more
    Nov 14, 2022

    Health Volunteer Trial (RBD5044, Placebo)

    Not yet recruiting
    • Health Volunteer
    • (no location specified)
    Sep 13, 2022

    Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

    Completed
    Has Results
    • Myelodysplastic Syndrome
    • SyB C-1101
    • Nagoya, Aichi, Japan
    • +3 more
    Nov 14, 2022

    Severe Hypertriglyceridemia Trial (Pegozafermin, Placebo)

    Not yet recruiting
    • Severe Hypertriglyceridemia
    • (no location specified)
    May 2, 2023

    Degenerative Osteoarthritis Trial (TG-C, Placebo Control)

    Not yet recruiting
    • Degenerative Osteoarthritis
    • TG-C
    • Placebo Control
    • (no location specified)
    Dec 22, 2022

    Diabetic Polyneuropathy, Amputation Trial in Ankara (Joint Position Sense Analysis)

    Not yet recruiting
    • Diabetic Polyneuropathy
    • Amputation
    • Joint Position Sense Analysis
    • Ankara, Altindag, Turkey
      Hacettepe University
    Sep 13, 2022

    Acceptability ofPrEP Program Among MSM and Transgender and

    Not yet recruiting
    • HIV Infections
    • STI
    • acceptability of a PrEP program among HIV-negative MSM and TG
    • (no location specified)
    Jul 10, 2023

    Severe Hypertriglyceridemia Trial in Canada, United States (Olezarsen, Placebo)

    Recruiting
    • Severe Hypertriglyceridemia
    • Birmingham, Alabama
    • +24 more
    Jan 25, 2023

    Severe Hypertriglyceridemia Trial in Worldwide (Olezarsen, Placebo)

    Recruiting
    • Severe Hypertriglyceridemia
    • Chula Vista, California
    • +109 more
    Jan 23, 2023

    Degenerative Osteoarthritis Trial in United States (TG-C, Placebo Control)

    Recruiting
    • Degenerative Osteoarthritis
    • TG-C
    • Placebo Control
    • Birmingham, Alabama
    • +34 more
    Dec 23, 2022

    Degenerative Disc Disease Trial (TG-C High Dose, TG-C Mid Dose, TG-C Low Dose)

    Not yet recruiting
    • Degenerative Disc Disease
    • TG-C High Dose
    • +3 more
    • (no location specified)
    Nov 17, 2023

    Familial Hypertriglyceridemia Trial (Heredity for cardiovascular disease, Heredity for pancreatitis, Heredity for type 2

    Active, not recruiting
    • Familial Hypertriglyceridemia
    • Heredity for cardiovascular disease
    • +3 more
    • (no location specified)
    Oct 23, 2023

    NAFLD, Type 2 Diabetes Trial in Aarhus N (High-fat mixed-meal tolerance test (HF-MMTT))

    Recruiting
    • NAFLD
    • Type 2 Diabetes
    • High-fat mixed-meal tolerance test (HF-MMTT)
    • Aarhus N, Denmark
      Department of Endocrinology and Internal Medicine
    May 23, 2022

    Hypertriglyceridemia, Cardiovascular Diseases, Atherosclerosis Trial in United States (Olezarsen, Placebo)

    Recruiting
    • Hypertriglyceridemia
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Jan 26, 2023

    Hypertriglyceridemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia Trial in Canada, United States

    Active, not recruiting
    • Hypertriglyceridemia
    • +2 more
    • Lincoln, California
    • +23 more
    Nov 23, 2022

    Postprandial Triglyceride and Glucose Responses

    Completed
    • Lipid Metabolism
    • Glucose Metabolism
    • Mixed meal challenge test
    • +4 more
    • Wageningen, Gelderland, Netherlands
      Stichting Wageningen Research
    Jul 4, 2022